US 9278091
Compounds for the treatment of Clostridium difficile associated disease
granted A61KA61K31/4164A61K31/424
Quick answer
US patent 9278091 (Compounds for the treatment of Clostridium difficile associated disease) held by SUMMIT THERAPEUTICS PLC expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUMMIT THERAPEUTICS PLC
- Grant date
- Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/4164, A61K31/424, A61K31/4365, A61K31/437